What is the impact of SSRIs on bleeding risk in patients with endometriosis?

Tripdatabase
2025 · doi:10.5281/zenodo.17672603 · W7106256166
OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-17 ⓘ

This paper investigates the specific impact of selective serotonin reuptake inhibitors on bleeding risk in patients with endometriosis, noting that while general evidence links SSRIs to increased bleeding, data for this population are lacking.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-11 · read from full text ⓘ

This study addresses the gap in knowledge regarding the impact of selective serotonin reuptake inhibitors on bleeding risk specifically within the patient population suffering from endometriosis. While existing evidence indicates that SSRIs generally increase bleeding risks, particularly when combined with anticoagulants, this research highlights the absence of specific data for individuals with endometriosis. The paper underscores the need for targeted investigations to determine if the general association between SSRIs and hemorrhage applies directly to those managing endometriosis-related conditions. This paper is centrally about endometriosis — it explicitly investigates the safety profile of a common medication class for patients diagnosed with this condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The evidence suggests SSRIs are associated with an increased bleeding risk, especially when used with anticoagulants, but specific data on their impact in endometriosis patients are lacking.
Full text 509 characters · extracted from oa-doi-fallback · click to expand
Published November 21, 2025 | Version v1 Other Open What is the impact of SSRIs on bleeding risk in patients with endometriosis? Description The evidence suggests SSRIs are associated with an increased bleeding risk, especially when used with anticoagulants, but specific data on their impact in endometriosis patients are lacking. Files 6ea811a1-1f90-430a-8e35-9c81a3b16d98.pdf Files (18.4 kB) | Name | Size | Download all | |---|---|---| | md5:1d1f10249e70a4b1bf37d2a979e92bea | 18.4 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK